CD26/DPPIV cell membrane expression and DPPIV activity in plasma of patients with acute leukemia-Reference-Cited by-同舟云学术

CD26/DPPIV cell membrane expression and DPPIV activity in plasma of patients with acute leukemia

Published:2009-06-01 Issue:3 Volume:24 Page:708-714
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

de Andrade Camilla F. C. G.¹,Bigni Ricardo²,Pombo-de-Oliveira Maria S.³,Alves Gilda¹,Pereira Denise A.¹

Affiliation:

1. Laboratório de Genética Aplicada, Serviço de Hematologia do Hospital do Câncer I, Instituto Nacional de Câncer, Praça da Cruz Vermelha 23CEP 20230-130, Rio de Janeiro, RJ, Brazil

2. Serviço de Hematologia do Hospital do Câncer I, Instituto Nacional de Câncer, Praça da Cruz Vermelha 23CEP 20230-130, Rio de Janeiro, RJ, Brazil

3. Divisão de Medicina Experimental, Coordenação de Pesquisa, Instituto Nacional de Câncer, Rua André Cavalcanti, 37CEP 20231-050, Rio de Janeiro, RJ, Brazil

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756360802334800

Reference35 articles.

1. CD26, let it cut or cut it down

2. Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides

3. Regulation of the Receptor Specificity and Function of the Chemokine RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted) by Dipeptidyl Peptidase IV (CD26)-mediated Cleavage

4. Amino-terminal Truncation of Chemokines by CD26/Dipeptidyl-peptidase IV

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Cd26 in Breast Cancer and its Pan-Cancer Analysis;2024

2. CD26/DPP-4 in Chronic Myeloid Leukemia;Cancers;2022-02-11

3. The Serine Protease CD26/DPP4 in Non-Transformed and Malignant T Cells;Cancers;2021-11-26

4. An expanded role for dipeptidyl peptidase 4 in cell regulation;Current Opinion in Hematology;2020-06-01

5. CD26/DPP4 - a potential biomarker and target for cancer therapy;Pharmacology & Therapeutics;2019-06